We measured a comprehensive set of outcome measures after different surgical procedures for painful chronic pancreatitis (CP) at longterm follow-up. Background: Pain caused by CP can be alleviated through operative intervention with type of procedure depending on anatomical abnormalities. Outcome measures include functional (pain relief, quality of life [QoL]), medical (endoand exocrine function), and clinical (reoperation) results reported by patient. Methods: A cross-sectional cohort of 223 consecutive patients who underwent surgical drainage, head resection, or left-sided pancreas resection, depending on anatomical abnormalities, was analyzed. Participating patients were reassessed during a prospectively scheduled outpatient clinic visit. Results: At follow-up, 44 patients had died; 146 of 179 living patients consented to participate in the study. After 63 months (range: 14-268), 68% reported no or little pain, 19% reported intermediate pain, and 12% reported severe pain. Preoperative daily opioid use (OR: 3.04; 95% confidence interval [CI]: 1.09-8.49) and high numbers of preceding endoscopic procedures (OR [odds ratio]: 3.89; 95% CI: 1.01-14.9) were associated with persistent severe pain. Compared with the general population, physical more than mental QoL remained impaired (P < 0.05). At follow-up, endocrine insufficiency was present in 57% of patients and exocrine insufficiency was present in 77%. Independently, a head resection and a reoperation for any cause were moderately associated with new-onset diabetes (P < 0.1). Compared with patients who underwent left-sided resection, the risk of developing exocrine insufficiency after surgery was higher after drainage or head resection. After 20 months (interquartile range: 10-51) after surgery, 26 (12%) of 223 patients underwent 1 or more elective reoperations. Conclusions: Operative intervention for painful CP, tailored to anatomical abnormalities, results in excellent to fair long-term pain relief, but approximately 10% of patients do not respond. QoL scores remained slightly compromised. High preoperative pain levels, suggested through daily opioid use and high numbers of endoscopic procedures, are associated with less favorable outcome. (Ann Surg 2012;255:763-770) C hronic pancreatitis (CP) is a progressive, inflammatory condition causing irreversible damage of pancreatic parenchymal tissue. 1 Continuous or (superimposed) acute attacks of severe abdominal pain are the main complaint. Development of CP is probably due to a complex interrelationship of etiological factors, the most important being toxic-metabolic (alcohol), genetic predisposition, and recurrent and From the
severe acute pancreatitis. 2, 3 Prolonged disease ultimately results in impaired pancreatic function. Exocrine insufficiency leads to weight loss, steatorrhea, vitamin deficiency, and abdominal discomfort as a result from fat malabsorption due to lipase secretion impairment. Endocrine insufficiency results in pancreatogenic diabetes.
The principal indication for surgical treatment of CP is abdominal pain. Local complications that can occur in CP include a biliary stricture, duodenal stricture leading to gastric outlet obstruction, or symptomatic pseudocysts. Relevant abnormalities on imaging include the presence of a dilated pancreatic duct (PD), the level of obstruction, and the presence of an inflammatory mass in the head or tail of the pancreas. Another factor in treatment consideration is the concomitant suspicion of cancer. Although worldwide consensus and standardized criteria are presently not available, the general opinion is that the choice of surgical procedure for CP is based on clinical findings in combination with radiological findings.
CP at an advanced stage causes various clinical and functional complaints. As a general observation for chronic illnesses the burden of disease, eventually leading to surgical intervention, is largely subjective. Because the primary indication for surgical intervention in CP is pain, the patient-reported outcome (PRO) measures, pain relief, and quality of life (QoL) should be considered decisive endpoints. 4 Additional outcome measures that define treatment success include employment, weight, and pancreatic endo-or exocrine insufficiency requiring medication.
Although an appropriate surgical procedure can yield longterm pain relief, a minority of patients does not respond. Possible predisposing factors of failure to achieve complete long-term pain relief after surgery include preoperative use of opioids and occurrence of postoperative complications, as was recently published. 5 Persistent or recurrent pain or development of local complications could also lead to reoperation. [6] [7] [8] [9] Progression of disease might be the pathophysiological basis for late recurrence of pain, whereas an inappropriate primary procedure could prompt for an early reoperation. 8, 10 Controversy exists whether surgical PD drainage should always accompany resection. Some believe (minimal) resection should be part of any surgical procedure for CP, whereas others generally do not perform resection. 11, 12 The argument against drainage without resection is that these patients would be insufficiently treated, leading to early recurrence of pain. On the contrary, another recent study suggested that patients selected for a PD drainage procedure have a better postoperative QoL than those undergoing resectional procedures. 13 The objective was to investigate the long-term results of various surgical procedures for painful CP in terms of the clinical outcomes morbidity, rate and indication of elective reoperation, the PROs pain relief and QoL, and the medical outcomes endo-and exocrine pancreatic function and pharmacological control of insufficiency.
Academic Medical Center, Amsterdam, were selected for the present study, to guarantee a minimal follow-up of several years. Pure PD drainage, by performing a pancreaticojejunostomy (PJ) according to Partington-Rochelle (modified Puestow) , was restricted to patients with a dilated PD caused by strictures or stones, without an inflammatory mass (size pancreatic head <4 cm). 14 A jejunal loop was anastomosed side-to-side to the whole length of the pancreas from tail to head. Only in the presence of an inflammatory enlarged head of the pancreas of 4 cm or more in diameter, a drainage procedure combined with a local resection as described by Frey and Smith, 15 or a duodenum-preserving pancreatic head resection according to Beger, 16 depending on the surgeon's preference, was performed. Each procedure was extended with a biliodigestive anastomosis when obstructive jaundice or a common bile duct stent was present. Pancreatoduodenectomy, or the pylorus preserving modification, was performed only in case of severe duodenal obstruction or when CP was the most likely diagnosis but cancer could not be ruled out confidently. For distal obstruction, a left-sided pancreatectomy was performed. Patients who had undergone a pancreatoduodenectomy for suspicion of malignancy but who were found to have CP after pathological investigation were excluded.
Follow-Up, Questionnaires, and Tests
Clinicopathological data of patients undergoing pancreatic surgery in our clinic are permanently collected in a prospective database. Specific additional information on presenting symptoms, suspected cause, duration of disease, and previous (endoscopic) treatment was obtained from medical records. For follow-up investigation, general practitioners were contacted for the patient's present health status. For deceased patients, cause of death was noted. Living patients were contacted for participation and asked to self-complete various questionnaires and were invited to a single prospective visit to the outpatient clinic. Patients not able to visit the outpatient clinic were offered to be visited at home by one of the investigators. The questionnaires were mailed to patients' homes to avoid observer bias.
For pain assessment, the Dutch version of the Short Form McGill Pain Questionnaire was used, which consists of 11 sensory and 4 affective pain descriptors, each ranked in 4 intensity options, and a present pain intensity index and a visual analogue scale (VAS). 17, 18 The European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire C30 (QLQ-C30) and its CP module (QLQ-PAN28) were used as generic and disease-specific QoL instruments. 4, 19 The scores of both the QLQ-C30 and of the QLQ-PAN28 are linearly transformed to a scale of 0 to 100, with a higher score indicating better functioning or global QoL, or more symptoms or problems. We also included the Short Form-36 (SF-36) as a generic QoL instrument, whose 36 items are combined to form 8 subdomains and a composite physical and mental score. 20 Results of the SF-36 QoL scoring lists could be compared with a reference population, matched for age. 21 During the outpatient clinic visit, information on alcohol use, coexisting medical conditions, duration of complaints, and previous and current medication use was collected. Height and weight were measured to calculate body mass index (weight/height). To evaluate medical consequences, fasting blood glucose (FBG) was determined at the time of the outpatient clinic visit. Endocrine insufficiency was defined as a FBG level more than 6.7 mmol/L (121 mg/dL) or when receiving prescription antidiabetic medication (insulin, oral medication) for previously diagnosed diabetes mellitus, regardless of FBG level. Glycemic control by antidiabetic medication was considered adequate when the glycated hemoglobin level was less than 7%. Exocrine insufficiency was defined as a feces elastase level of less than 200 μg/g of feces (100-200: moderate; <100 severe), as was described by the manufacturer of the test. Preoperative feces elastase levels were unavailable in the majority of cases. Use of pancreatic enzymes was considered informative but not an alternative indication of pancreatic insufficiency, because they had also been prescribed as part of pain management.
Data Presentation and Statistical Analysis
In this cross-sectional cohort study, the results of the explorative analysis on clinical outcomes, pain and QoL scores, and medical outcomes are presented for the entire cohort and per operative procedure (resection, drainage, left-sided resection), where appropriate. The acknowledged association between opioid use and PROs was analyzed separately. 13, 22 We investigated potential predictive factors for poor response to surgery in terms of pain relief and medical consequences through regression analysis.
Comparisons between patient groups were performed using the χ 2 test or the Fisher exact test when appropriate. Summary statistics are presented either as mean with standard deviation (SD) or with standard error or median with interquartile range (IQR), depending on normal or nonnormal distribution. For continuous data, the Student t test, Mann-Whitney, or Kruskal-Wallis test were also performed where appropriate.
For the continuous SF-36 QoL outcome variables, comparisons between patients and reference population were made using Student t tests, irrespective of type of distribution due to the large sample normal distribution approximation rule. To determine the magnitude of the differences in means, effect sizes (ESs) were calculated. The ES is equal to the difference in mean scores of the 2 groups, divided by the SD of the reference population. Cohen interpreted ESs as small (0.2-0.49), moderate (0.5-0.79), or large (>0.8). 23 A "remarkable universality" among estimates of clinical significance is reported to center around an ES of 0.5 on QoL measures used in chronic disease patients. 24 Univariable linear and (multinomial) logistic regression analyses are performed for risk factors for pain, and endo-and exocrine insufficiency. Continuous variables were examined for linearity with the outcome measure and appropriately transformed or categorized if the relationship was clearly nonlinear. Multivariable regression analysis for association models was performed using both backward selection procedure of significant variables, defined as a P value of less than 0.05 and forward selection to investigate potential confounding.
RESULTS

Characteristics and Clinical Outcomes of the Entire Cohort
In the study period, 223 patients had undergone an operation for pain due to CP of which the characteristics are shown in Table 1 . Surgical PD drainage was the most frequently performed procedure in our cohort. Surgery-related morbidity during index intervention for the entire cohort was 22%; overall in-hospital mortality was 0.9% ( Table 2 ). An emergency relaparotomy for bleeding or anastomotic dehiscence complications was needed in 16 of 223 (7%) patients, although after the year 2000 bleeding complications were treated primarily through interventional radiology.
At a median follow-up of 60 (IQR: 29-104) months, 26 of 223 (12%) patients had undergone a total of 35 elective reoperations after a median interval of 20 (10th-90th percentile 4-66) months after the index procedure (Table 2 ). For 8 of these 26 (31%) patients, the first reoperation was performed within 12 months of the primary procedure. New-onset or recurrent cholestasis requiring a (revision of the) biliodigestive bypass was the most prevalent cause for reoperation. The proportion of patients that underwent any form of pancreatic head resection as initial procedure and required one or more reoperations during follow-up was significantly higher than patients who underwent a drainage procedure or a left-sided resection (P < 0.001). Of the 223 patients, 179 (80%) were alive at follow-up. Of the 44 patients who had died during the follow-up period, 6 died of a pancreatic adenocarcinoma.
STUDY PARTICIPANTS Patient-Reported Outcomes
Of the 179 living patients, 146 (82%) agreed to participate. The median follow-up time was 63 months (IQR: ). There were no Evaluated at time of surgical index procedure * Pancreaticojejunostomy according to Puestow. †Procedure according to Frey (n = 26), Beger (n = 9), or pancreatoduodenectomy (n = 5).
‡Supplement to drainage, head, or left-sided resection. statistically significant differences in baseline characteristics between patients who participated in the present study and those who did not (data not shown). Presumed etiology of CP of the follow-up cohort included the following: alcohol 52% (76 patients), idiopathic 25% (36 patients), biliary 7% (11 patients), and other causes (eg, postnecrotic, pancreas divisum) 16% (23 patients). Alcohol as cause of CP had lowest prevalence in patients that underwent left-sided resection and highest among patients that underwent head resection, respectively, 32% (7 patients) and 78% (18 patients). Of the 146 patients, 110 (75%) were active cigarette smokers at the time of operation with 23 (IQR: 15-34) median pack-years (1 pack per day), 17 (12%) were past smokers. Of these 110 active smokers, 99 (90%) had continued smoking up to the follow-up investigation. Table 3 shows mean VAS pain scores for all patients, and per type of procedure. When categorized in 3 groups (low VAS <4; intermediate VAS 4-7; severe VAS >7) proportions were 68% (100 patients), 19% (28 patients), and 12% (18 patients), respectively. For the 18 patients with severe pain at follow-up, the mostly reported highest ranked sensory dimension of pain description was "tender" (56%, 10 patients), highest ranked affective dimensions were "tiringexhausting," and "fearful." Reported McGill Present Pain Intensity descriptive scores were the following: no pain 47.6% (68 patients), mild 20.3% (29 patients), discomforting 21% (30 patients), distressing 4.9% (7 patients), horrible 5.6% (8 patients), and excruciating 0.7% (1 patient). VAS scores of pain and pain intensity scores did not differ significantly between patients who underwent any type of resection or drainage as primary type of procedure. Table 3 also shows the mean symptom scores of selected QLQ-C30 and -PAN28 domains for which more than 25% of patients report a score greater than 50 (moderate-severe). The proportion of patients that reported moderate-severe symptoms on the closely related domains flatulence, bloated abdomen, indigestion, and altered bowel Mean values with standard deviation are given and percentage of patients with high pain scores or compromised QoL (unless otherwise stated). High pain score defined as score >7.0 on visual analog scale; compromised QoL on all other domains defined as score >50. habit was relatively low for the left-sided resection group compared with the other 2 procedures. Domain and component scores of SF-36 for assessment of generic QoL are summarized in Table 4 . Compared to a reference population matched for age, CP patients scored significantly lower on all domains, but the magnitude of the differences in mean scores was primarily small to moderate (range: 0.26-0.70), with the exception of the domains physical functioning (ES = 0.83) and general health perceptions (ES = 1.08). Compared with the reference population, lower composite scores for CP patients were more explicit on the physical than on the mental QoL domain.
Among the different presumed etiological causes of CP, the distribution of categorized VAS pain scores was not significantly different. Of the 146 patients, 100 (68%) had undergone 1 or more endoscopic attempts to relieve pain before surgery. Multinomial univariable logistic regression analysis with the categorized VAS pain score as dependent variable showed that a higher number of preoperative endoscopic procedures (>5), preoperative daily opioid use, and reoperation were associated with severe pain at follow-up (Table 5 ). Patients who required an elective (revision of) head resection for pain had a mean VAS pain score at follow-up of 5.1 (SD: 3.2); this score was 2.8 (SD: 2.7) for other patients (P = 0.019).
Of the 146 patients, 50 (34%) had paid employment at the time of follow-up and 15 were following reintegration, whereas 75 (51%) received social security and 21 (14%) had retired.
Outcomes Defined by Opioid Use
Compared with nonuser patients who, at the time of surgical intervention, presented with daily opioid use were younger, 45.4 (SD: 10.2) years versus 50.7 (SD: 10.8) years for nonusers (P = 0.001), and had a longer median reported duration of pain, 48 (10th-90th percentile: 12-192) months versus 36 (10th-90th percentile: 12-120) months (P = 0.021) for nonusers. No significant difference between groups in prevalence of diabetes or number of previous therapeutic endoscopic procedures at the time of surgical intervention was found. There was a trend for patients with preoperative opioid use to undergo some form of resection (Frey, Beger, Pancreatoduodenectomy) rather than surgical drainage alone (P = 0.08).
Daily opioid use had decreased from 33% (48/146) of patients preoperatively to 17% (25/146) at follow-up (30 stopped, 18 continued, 7 started). After surgery, 93% (91/98) of the preoperative nonusers had remained opioid-free, whereas 63% (30/48) of the preoperative users became opioid-free. The median reported VAS score of pain for patients who preoperatively used opioids and quit using after surgery was significantly lower at follow-up compared ‡Reference category is 0-1 previous endoscopic procedure. §Reference category is tail resection. Head resection in relation to drainage also not significantly different. Related to sequelae of chronic pancreatitis: cholestasis, recurrent pain, gastric outlet obstruction or suspicion of malignancy.
Medical Outcomes-Pancreatic Function and Pharmacological Control
¶Variable confined to patients that consumed alcohol prior to surgery and continued. #Variable confined to patients that smoked cigarettes prior to surgery and continued. * * Significant at the P < 0.05 level. Table 7 displays the regression analysis of relevant risk factors for development of diabetes during follow-up after operation for CP. A head resection, a reoperation for any cause, and longer follow-up after surgery were moderately associated with new-onset diabetes.
Preoperatively 63 patients (46%) received pancreatic enzyme supplements, whereas at follow-up exocrine insufficiency was present in 95 patients (77%). Compared with patients who underwent leftsided resection the risk to develop exocrine insufficiency after surgery was higher after drainage or some form of resection; OR: 3.81 (95% CI: 1.38-10.5) and OR: 7.73 (95% CI: 1.42-42.2), respectively. No other predisposing factors were identified. Overall mean body mass index increased from 21.8 (95% CI: 21.1-22.5) preoperatively to 23.0 (95% CI: 22.3-23.7) at follow-up (P < 0.001). 
DISCUSSION
In the present study, we found that partial to complete pain relief is achieved in the majority of patients after operation for painful CP, but 12% does not respond, mainly characterized by continued opioid dependency. High preoperative pain levels, suggested by daily opioid use and high numbers of endoscopic procedures, predisposes for a less favorable long-term outcome after operation with respect to pain relief and QoL. In all patients, long-term QoL after surgery remains slightly compromised compared with a reference population, particularly in the physical domains. Opioid dependency at followup is associated with poor QoL and severe pain. During follow-up, overall elective reoperation rate for any cause was 12%. Patients who underwent any form of resection of the pancreatic head had an increased risk for elective reoperation. Elective reoperation and any form of head resection were moderately associated with new-onset diabetes. A substantial proportion of patients developed exocrine insufficiency at long-term follow-up.
The indication to operate in the present series was pain. Several descriptive and randomized series report long-term pain relief ranging from 48% up to even 100%. 6, [25] [26] [27] Nevertheless, to compare results among these series is complicated because of heterogeneity in duration of follow-up and outcome measures (eg, ad hoc instead of validated questionnaires for pain and QoL). Also, when evaluating the primary endpoint, pain relief after surgery for painful CP and proper selection of the study population is important. For example, patients who were operated for suspicion of pancreatic malignancy that turned out to be CP at histopathology should not but are indeed included in several studies. 7, 13, 22, 28, 29 Not all of these patients present with intractable, epigastric pain but different clinical symptoms and likely they might, when included, lower the pain score. Including these patients contaminates study results and interpretation of actual outcome of operative intervention for painful CP.
The 12% elective reoperation rate was mainly for (recurring) cholestasis and pain, which resembles rates and indications of several other large series. 7, 8, 27 Patients who had undergone any form of resection of the pancreatic head were at higher risk for reoperation than those who had undergone surgical drainage or left-sided resection. The majority of reoperations were carried out more than 12 months after the primary procedure, which might suggest that the need for a reoperation reflect progression of disease rather than an inappropriately applied primary procedure. On the contrary, it might be that the treating physician choose to wait up to a year before the final conclusion of treatment success or failure could be drawn. Nevertheless, persistent pain after index surgery prompting for a (revision of) head resection, although it concerned a small number of patients, was still associated with high pain scores at long-term follow-up. Likely due to progressive disease, elective secondary (more extensive) surgery for failure of pain relief after an initial attempt, seems rarely indicated.
For decades, the Puestow procedure was the one surgical (drainage) option to treat pain in CP. 30 Failure to respond or recurrence of pain has been attributed to lack of dilated ductal disease, improper surgical technique (PD not incised over the full length), or persistent or recurrent disease in the head of the pancreas. [30] [31] [32] We found that an increasing number of endoscopic treatment procedures before operation were associated with less favorable long-term outcome. Besides failure to achieve adequate and long-term relief of symptoms, these repeated endoscopic attempts also result in a postponement of surgical intervention to a more advanced disease stage. 33 Possibly these patients are less likely to respond to surgical treatment at that time.
From a technical point of view, the principal cause of failure of the Puestow operation is the fact that the procedure does not address a potential inflammatory mass, by some considered to be the pacemaker of pain. 30, 34 It is for this reason that some surgeons believe (minimal) resection should be part of any surgical procedure for CP, and it might explain the rapid and firm rise in popularity of the organ-sparing resection procedures. 35 A pancreatic head diameter of 4 cm or more is the threshold we use to decide for a local resection of the pancreatic head. 33 Patients with a pancreatic head smaller than this threshold are considered candidates for surgical drainage only. In pursuing this guideline, we found the majority of our patients reported excellent to acceptable pain relief on the long term, irrespective of surgical procedure. Moreover, the presumed higher risk of recurrence of pain or local symptoms after drainage, prompting for reoperation, cannot be confirmed. On the contrary, a higher reoperation rate was found for pain after head resection compared to drainage only. Although this most likely reflects the presence of more extensive and progressive disease in the patients with resection and thus "big heads," a disadvantage of drainage only in the patients with "small heads" was not seen. An external factor that explains our relatively high number of drainage procedures compared with other published series probably reflects local referral patterns to surgeons, which was discussed earlier. 36, 37 Like others, we experience that patients with a big pancreatic head due to an inflammatory mass in the pancreatic head are relatively rare and are referred less for surgical treatment in The Netherlands than in other countries. 38 Failure of response to surgical treatment in CP can also be caused by patient factors, of which continued heavy alcohol use has been suggested to be an important factor. [39] [40] [41] [42] However, conflicting results in the literature exist with respect to the significance of this association. [43] [44] [45] In line with recent other studies, our study did not reveal a significant association between continued moderate or heavy alcohol use and persistent pain. 8, 27, 31, 46 Furthermore, there was no significant relationship between the QLQ-PAN28 items that measure guilt and burden of abstention from alcohol, and overall QoL. These findings were equal for any type of preceding primary surgical procedure. We could hypothesize that patients who drink alcohol are essentially the ones that are pain-free and report a high QoL. Of significance in the pathogenesis of CP is the suggested relationship with (cigarette) smoking, which was also likely to be contributing factor in our cohort, considering the very high prevalence of three-quarters of patients smoking at the time of operation. 47, 48 However, this variable did not play a major part in failure of treatment as the vast majority of smokers continued smoking after surgery.
The fact that CP is a debilitating condition that leads to severe pain and progressive loss of endo-and exocrine function, ultimately resulting in insulin requirement and gastrointestinal symptomsmalabsorption, anorexia, weight loss-is well-recognized. In contrast to these "hard" endpoints, the emotional and social consequences of CP are less clear. However, an increased awareness of the importance to assess impact and treatment of CP on patients' QoL has emerged and has led to development of CP-specific and validated QoL scoring systems. 4 We found that a considerable number of CP patients still report an impaired QoL on various domains like fatigue, insomnia, and fear of future health after surgery. This finding underlines the multidimensional effects of the disease and highlights the need for counseling of patients with this chronic illness. Furthermore, we observed from the multivariable analysis that daily opioid use and reoperation, probably reflecting progressive disease activity, were the strongest factors associated with a worse physical and mental QoL at follow-up. The experienced physical QoL was more impaired than mental QoL, which suggests that patients experience a profound limitation in performing all physical activities, including self-care, work, and social and role activities, mainly due to pain. A relatively good mental QoL should be interpreted as frequent positive affect, and absence of psychological distress and limitations in usual social activities due to emotional problems.
The majority of patients were operated without ever having used opioids and remained free from opioids after surgery. Two-thirds of the preoperative opioid users became opioid-free after surgery. VAS pain scores for both types of patients were nearly 1.0 postoperative, but significantly higher for current users. The dramatic effects associated with daily opioid dependency were also specifically evident for current users, who had worse outcomes on almost every QoL domain of every scale compared with nonusers. Current nonusers closely resembled a healthy reference population. Although one could argue that patients without opioid use could have been managed conservatively, we question the wait-and-see approach, because CP is considered a chronic and progressive disease and symptoms are likely to increase. In line with others who found that opioid withdrawal was more problematic in those with preoperative opioid use, we agree with the view that earlier referral for resection may be warranted. 49, 50 We hypothesize that surgical intervention may be even more effective with respect to long-term outcomes when performed early in the course of disease, before arriving to the stage of necessary administration of opioids.
Long-term exocrine and/or endocrine insufficiency in CP patients treated surgically is due to the surgical intervention and the progression of the underlying disease. 51 A recent review showed that when some kind of resection procedure is indicated for pancreatic head disease in CP, the more organ-sparing variants like the Frey or Beger procedure are preferred to pancreatoduodenectomy for their favorable effects on endocrine and exocrine function. 52 In the present series, we found that a head resection and reoperation were more frequently associated with the development of new-onset diabetes than a drainage procedure. Although the number of patients with endoand/or exocrine insufficiency was considerable, this did not importantly influence the overall reported QoL, which concords with results found by others. 46 The timing of intervention may be another factor that determines the extent of pancreatic insufficiency. In an experimental study using a porcine model, we found that early surgical drainage resulted in a marked improvement in histopathology grades and pancreatic exocrine function as opposed to the late drainage group. 53 Nealon et al 54, 55 advocate a policy of early surgical drainage before the development of irreversible functional impairment, based on the clinical finding that decompression via a PJ delays exocrine functional impairment. Therefore, patient selection for early surgical drainage as opposed to prolonged conservative or endoscopic treatment seems advisable.
Our study has some limitations. We performed a retrospective analysis of a series of patients and scheduled a single prospective QoL measurement in time, precluding a longitudinal analysis. The possibility that patients had lower VAS pain scores preoperatively cannot be ruled out, but it seems highly unlikely, considering the fact that all patients were multidisciplinarily indicated to undergo an operation for pain due to CP. With respect to one of our main findings (higher numbers of endoscopic attempts are associated with poor response to surgery), the nonresponders might have been those who initially had greater pain severity and were more likely to seek out consultation and accept attempts at endoscopic therapy. Further potential selection bias may be that patients happy with their treatment responded more willing to participate to the follow-up study. This may temper the strength of our findings. Nevertheless, this influence is possibly limited because we achieved a very high participation rate of 82% of living patients. Finally, we feel that our surgical approach tailored to anatomical abnormalities, that is, no head resection when the diameter is less than 4 cm is supported by the reported excellent to fair PROs. Still, the retrospective nature of our study restricts the level of evidence of this conclusion. However, we question the theory that patients with a dilated duct and no parenchymal enlargement, who according to our policy undergo a PJ, might have done better had they undergone a head resection. The potential room for improvement had all drainage patients undergone a head resection instead is limited considering their already excellent results.
In conclusion, an operative intervention for painful CP, tailored to anatomical abnormalities, results in excellent to fair long-term pain relief. To perform surgical drainage in the absence of an enlarged head is more likely to preserve pancreatic function and as comparable PROs were obtained for resection and drainage procedures in selected patients, this supports a tailored approach. Operative failures may not be explained by differences in the underlying anatomical disorder, and a tailored surgical approach may thereby have an inherent, although modest, failure rate. This failure rate may improve once we achieve a better understanding of the pathogenesis of pancreatic neuropathic pain. Surgical intervention may be even more effective with respect to long-term outcomes when performed early in the course of disease, when the patient suffers from moderate pain levels, and before arriving to the stage of necessary administration of opioids. However, future research should be performed to investigate this assumption and provide high level of evidence.
